Clinical Trial Update: Efficacy and Safety of OncoGel™ Added to Chemotherapy and Radiation Before Surgery in Subjects With Esophageal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating OncoGel added to chemotherapy and radiation before surgery in esophageal cancer; the study is terminated with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenocarcinoma of the Esophagus
• Esophageal Cancer
• Squamous Cell Carcinoma

Drugs mentioned

• OncoGel

Snippet

Sponsor: Boston Scientific Corporation | Conditions: Esophageal Cancer, Adenocarcinoma of the Esophagus | Phase 2 | Status: TERMINATED | Results posted: 2014-05-16